These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35647354)

  • 1. Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities.
    Morales DE; Mousa S
    Heliyon; 2022 May; 8(5):e09517. PubMed ID: 35647354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
    Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology for Treatment of Glioblastoma Multiforme.
    Michael JS; Lee BS; Zhang M; Yu JS
    J Transl Int Med; 2018 Sep; 6(3):128-133. PubMed ID: 30425948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.
    Sandbhor P; Goda J; Mohanty B; Chaudhari P; Dutt S; Banerjee R
    Nanoscale; 2021 Dec; 14(1):108-126. PubMed ID: 34897360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
    Sukumar UK; Bose RJC; Malhotra M; Babikir HA; Afjei R; Robinson E; Zeng Y; Chang E; Habte F; Sinclair R; Gambhir SS; Massoud TF; Paulmurugan R
    Biomaterials; 2019 Oct; 218():119342. PubMed ID: 31326657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management.
    Upadhaya PG; Pulakkat S; Patravale VB
    Drug Deliv Transl Res; 2020 Aug; 10(4):1044-1056. PubMed ID: 32221847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of polymeric micelles in the context of glioblastoma therapy.
    Morshed RA; Cheng Y; Auffinger B; Wegscheid ML; Lesniak MS
    Front Pharmacol; 2013 Dec; 4():157. PubMed ID: 24416018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.
    Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C
    Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme.
    Aldoghachi AF; Aldoghachi AF; Breyne K; Ling KH; Cheah PS
    Neuroscience; 2022 May; 491():240-270. PubMed ID: 35395355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China.
    Wang Y; Zhang J; Li W; Jiang T; Qi S; Chen Z; Kang J; Huo L; Wang Y; Zhuge Q; Gao G; Wu Y; Feng H; Zhao G; Yang X; Zhao H; Wang Y; Yang H; Kang D; Su J; Li L; Jiang C; Li G; Qiu Y; Wang W; Wang H; Xu Z; Zhang L; Wang R
    Future Oncol; 2021 Nov; 17(33):4571-4582. PubMed ID: 34519220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery.
    Brar HK; Jose J; Wu Z; Sharma M
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients.
    Ene CI; Cimino PJ; Fine HA; Holland EC
    Neurosurg Focus; 2020 Oct; 49(4):E11. PubMed ID: 33002863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
    van Woensel M; Wauthoz N; Rosière R; Amighi K; Mathieu V; Lefranc F; van Gool SW; de Vleeschouwer S
    Cancers (Basel); 2013 Aug; 5(3):1020-48. PubMed ID: 24202332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in nanotechnology for the treatment of GBM.
    Wei D; Zhang N; Qu S; Wang H; Li J
    Front Neurosci; 2023; 17():1180943. PubMed ID: 37214394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers.
    Delello Di Filippo L; Hofstätter Azambuja J; Paes Dutra JA; Tavares Luiz M; Lobato Duarte J; Nicoleti LR; Olalla Saad ST; Chorilli M
    Eur J Pharm Biopharm; 2021 Nov; 168():76-89. PubMed ID: 34461214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy.
    Yasaswi PS; Shetty K; Yadav KS
    J Control Release; 2021 Aug; 336():549-571. PubMed ID: 34229001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma Multiforme-A Look at the Past and a Glance at the Future.
    King JL; Benhabbour SR
    Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.